Type of lung cancer-Non-small cell lung carcinoma (NSCLC)-Large cell carcinoma Posts on Medivizor

Posted by Medivizor on Dec 11, 2018 in Lung cancer | 0 comments

In a nutshell This study wanted to find which combination of medications worked best for advanced non-small cell lung cancer, nab-paclitaxel (Abraxane) alone, or nab-paclitaxel plus CC-486. The study found that there was no benefit seen when CC-486 was added to treatment with nab-paclitaxel.   Some background There are a number of options for...

Posted by Medivizor on Aug 8, 2018 in Lung cancer | 0 comments

In a nutshell This study looked at the benefit of adding the immunotherapy drug atezolizumab (Tecentriq) to bevacizumab (Avastin) and chemotherapy. The authors stated that combining atezolizumab to bevacizumab and chemotherapy treatment improved progression free survival and overall survival for patients with advanced non-small-cell lung cancer....